Table 2.
Univariate Cox regression analysis of CHIP or Gal1 expression and clinicopathological variables predicting survival in patients with CRC patients
| Variables | n=470 cases | |
|---|---|---|
| HR (95 % CI) | P | |
| Age (≤65 vs. > 65) | 1.607 (1.215-2.126) | 0.001 |
| Gender (male vs. female) | 1.013 (0.762-1.347) | 0.927 |
| Pathological classification (I/II vs. III) | 2.475 (1.587-3.860) | <0.001 |
| Depth of invasion (T1/T2 vs. T3/T4) | 3.687 (2.270-5.990) | <0.001 |
| Lymph node metastasis (N0 vs. N1/N2) | 2.807 (2.112-3.731) | <0.001 |
| TNM stage (I/II vs. III/IV) | 3.214 (2.407-4.291) | <0.001 |
| Distant metastasis(M0 vs. M1) | 8.150 (4.849-13.699) | <0.001 |
| Tumor diameter (≤5 cm vs. >5 cm) | 1.196 (0.848-1.688) | 0.307 |
| CHIP expression (low vs. high) | 0.314 (0.235-0.419) | <0.001 |
| Gal1 expression (low vs. high) | 0.373 (0.281-0.495) | <0.001 |